| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.5M | -3.2% |
| SG&A Expense | $20.6M | +110.8% |
| Operating Income | -$36.2M | -40.0% |
| Interest Expense | $3.3M | +28.2% |
| Income Tax | $0 | — |
| Net Income | -$36.8M | -31.4% |
| EPS (Basic) | -$1.30 | -27.5% |
| EPS (Diluted) | -$1.30 | -27.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.1M | -4.3% |
| Short-term Investments | $47.1M | +4565.8% |
| Inventory | $1.2M | — |
| Current Assets | $123.3M | +57.5% |
| Total Assets | $124.2M | +57.1% |
| Current Liabilities | $7.4M | -50.0% |
| Long-term Debt | $36.8M | +114.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.6M | -27.4% |
| Capital Expenditures | $21K | +133.3% |
| Investing Cash Flow | -$45.9M | -242.7% |
| Financing Cash Flow | $77.2M | +3152.5% |
| Free Cash Flow | -$34.6M | -27.4% |
| Total Liabilities |
| $51.8M |
| +129.4% |
| Stockholders' Equity | $72.4M | +28.3% |